Herzog H - Search Results

1

Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous yttrium-90 radiotherapeutics.

Herzog H, Rösch F, Stöcklin G, Lueders C, Qaim SM, Feinendegen LE. Herzog H, et al. J Nucl Med. 1993 Dec;34(12):2222-6. J Nucl Med. 1993. PMID: 8254415 Free article.

2

Noninvasive assessment of regional cardiac adenosine using positron emission tomography.

Deussen A, Henrich M, Hamacher K, Borst MM, Herzog H, Coenen HH, Stöcklin G, Feinendegen LE, Schrader J. Deussen A, et al. Among authors: herzog h. J Nucl Med. 1992 Dec;33(12):2138-44. J Nucl Med. 1992. PMID: 1460505 Free article.

3

Brain and brain tumor uptake of L-3-[123I]iodo-alpha-methyl tyrosine: competition with natural L-amino acids.

Langen KJ, Roosen N, Coenen HH, Kuikka JT, Kuwert T, Herzog H, Stöcklin G, Feinendegen LE. Langen KJ, et al. Among authors: herzog h. J Nucl Med. 1991 Jun;32(6):1225-9. J Nucl Med. 1991. PMID: 2045937 Free article.

4

The comparison of 2-18F-2-deoxyglucose and 15-(ortho-123I-phenyl)-pentadecanoic acid uptake in persisting defects on thallium-201 tomography in myocardial infarction.

Henrich MM, Vester E, von der Lohe E, Herzog H, Simon H, Kuikka JT, Feinendegen LE. Henrich MM, et al. Among authors: herzog h. J Nucl Med. 1991 Jul;32(7):1353-7. J Nucl Med. 1991. PMID: 2066789 Free article.

5

SPECT studies of brain tumors with L-3-[123I] iodo-alpha-methyl tyrosine: comparison with PET, 124IMT and first clinical results.

Langen KJ, Coenen HH, Roosen N, Kling P, Muzik O, Herzog H, Kuwert T, Stöcklin G, Feinendegen LE. Langen KJ, et al. Among authors: herzog h. J Nucl Med. 1990 Mar;31(3):281-6. J Nucl Med. 1990. PMID: 2155314 Free article.

6

Quantification of the whole-body distribution of PET radiopharmaceuticals, applied to 3-N-([18F]fluoroethyl)spiperone.

Herzog H, Coenen HH, Kuwert T, Langen KJ, Feinendegen LE. Herzog H, et al. Eur J Nucl Med. 1990;16(2):77-83. doi: 10.1007/BF01465913. Eur J Nucl Med. 1990. PMID: 2311622

7

Pharmacokinetics and radiation dose of oxygen-15 labelled butanol in rCBF studies in humans.

Herzog H, Seitz RJ, Tellmann L, Schlaug G, Kleinschmidt A, Nebeling B, Stöcklin G, Müller-Gärtner HW. Herzog H, et al. Eur J Nucl Med. 1994 Feb;21(2):138-43. doi: 10.1007/BF00175761. Eur J Nucl Med. 1994. PMID: 8162937

8

Kinetics of 14(R,S)-fluorine-18-fluoro-6-thia-heptadecanoic acid in normal human hearts at rest, during exercise and after dipyridamole injection.

Ebert A, Herzog H, Stöcklin GL, Henrich MM, DeGrado TR, Coenen HH, Feinendegen LE. Ebert A, et al. Among authors: herzog h. J Nucl Med. 1994 Jan;35(1):51-6. J Nucl Med. 1994. PMID: 8271060 Free article.

9

The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas.

Langen KJ, Braun U, Rota Kops E, Herzog H, Kuwert T, Nebeling B, Feinendegen LE. Langen KJ, et al. Among authors: herzog h. J Nucl Med. 1993 Mar;34(3):355-9. J Nucl Med. 1993. PMID: 8441023 Free article.

10

Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography.

Rösch F, Herzog H, Plag C, Neumaier B, Braun U, Müller-Gärtner HW, Stöcklin G. Rösch F, et al. Among authors: herzog h. Eur J Nucl Med. 1996 Aug;23(8):958-66. doi: 10.1007/BF01084371. Eur J Nucl Med. 1996. PMID: 8753686

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

804 results

Search Page

Filters